JUNIPERUS/BERBERIS comp. capsules

Pack size:90 pieces Dosage form:Capsules

Juniperus/Berberis comp., capsules, soft capsules. Indications: According to anthroposophical understanding of man and nature. These include: Stimulating the sensory and warmth organization in the kidney area in cases of excretory weakness, e.g., kidney stones, gout, and flatulence (flatulence).

For risks and side effects, read the package insert and ask your doctor or pharmacist.


PACKAGE LEAFLET: INFORMATION FOR THE USER

Juniperus/Berberis comp., capsules, soft capsules

Composition:
1 soft capsule contains: Acorus calamus e rhizoma ferm 33d Ø 0.0915 mg (HAB, Vs. 33d), Anisi stellati aetheroleum 9.15 mg, Berberis vulgaris e radice W 10% 27.45 mg (HAB, Vs. 12f with virgin olive oil), D-Camphor 0.0915 mg, Eucalyptus aetheroleum 18.3 mg, Foeniculi amari fructus aetheroleum 9.15 mg, Iecoris aselli oleum A 45.75 mg, Juniperi aetheroleum 9.15 mg, Lini oleum virginale 457.5 mg, Pini pumilionis aetheroleum 9.15 mg, Ricini oleum virginale 45.75 mg, Solidago virgaurea ex herba ferm 33c Dil. D3 0.0915 mg (HAB, Vs. 33c), Terebinthina laricina 0.0915 mg, Terebinthinae aetheroleum rectificatum 9.15 mg, Tritici aestivi oleum raffinatum 183.0 mg. Other ingredients: Gelatin, Glycerol 85%, Cocoa butter, Virgin olive oil, Purified water. Indications

:
According to the anthroposophical understanding of man and nature. These include: Stimulation of the sensory and warmth organization in the kidney area in cases of excretory weakness, e.g., kidney stones, gout, flatulence (meteorism).

Contraindications:
This medicine must not be used in the following cases:

• inflammatory kidney diseases.
• known hypersensitivity to preparations of juniper berries (Juniperi aetheroleum), goldenrod (Solidago virgaurea), larch resin (Terebinthina laricina), purified essential oil from the turpentine of pine species (Terebinthinae aetheroleum rectificatum), linseed, cineole, camphor, star anise, anise, anethole, fennel or other umbelliferous plants as well as to any of the other ingredients of the medicinal product.

Due to the ingredient calamus root, Juniperus/Berberis comp. capsules should not be used during pregnancy and breastfeeding, or in children under 12 years of age.

Interactions with other medications:
Eucalyptus oil induces the enzyme system that breaks down foreign substances (increases the effect of the body's own substances that, among other things, break down medications) in the liver. The effect of other medications may therefore be weakened and/or shortened.

Dosage and method of administration:
Unless otherwise prescribed, take one soft capsule 1 to 3 times daily after meals with plenty of liquid. No more than 3 soft capsules should be taken per day.

Duration of use:
Because the medicine contains fennel oil, Juniperus/Berberis comp. capsules should not be taken for several weeks without consulting a doctor. The duration of treatment for chronic illnesses requires consultation with a doctor.

Side effects:
Long-term use or overdose can cause kidney damage. In sensitive patients, Juniperus/Berberis comp. capsules may trigger hypersensitivity reactions (including shortness of breath).

Contents:
90 capsules .

Pharmaceutical owner and manufacturer:
WALA Heilmittel GmbH,
Dorfstraße 1,
73087 Bad Boll/Eckwälden.

This leaflet was last revised in January 2025.

Source: Information from the Wala catalog,
as of April 2025.

Areas of application: According to anthroposophical understanding of man and nature. These include: stimulation of the sensory and warmth organization in the kidney area in cases of excretory weakness, e.g., kidney stones, gout, flatulence (meteorism).